Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Health system perspective regarding glycoprotein IIb/IIIa inhibitor therapy.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/CD3AF9C5.svg?ark=w1%2F20260515%2FCD3AF9C5)](https://nobleid.org/work/w1/20260515/CD3AF9C5)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors